| |
| |
|
| Insider
Information: |
Chondros Dimitrios |
| Relationship: |
SVP, Chief Medical Off... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
38,584 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,488,185 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
38,584 |
|
|
| Total
Value |
$1,488,185 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
SVP, Chief Medical Off... |
2019-08-03 |
38,584 |
2018-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-08-03 |
4 |
S |
$16.70 |
$22,178 |
D/D |
(1,328) |
38,584 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-06-01 |
4 |
D |
$14.75 |
$10,414 |
D/D |
(706) |
39,912 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,043 |
40,618 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-02-22 |
4 |
D |
$16.81 |
$22,576 |
D/D |
(1,343) |
38,575 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,884 |
39,918 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-02-14 |
4 |
D |
$16.54 |
$38,406 |
D/D |
(2,322) |
36,067 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,790 |
38,389 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-02-03 |
4 |
D |
$16.12 |
$40,348 |
D/D |
(2,503) |
31,599 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2019-02-03 |
4/A |
S |
$16.41 |
$41,616 |
D/D |
(2,536) |
31,566 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2018-08-03 |
4 |
D |
$17.08 |
$22,289 |
D/D |
(1,305) |
34,102 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2018-06-01 |
4 |
D |
$18.59 |
$13,236 |
D/D |
(712) |
35,407 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Medical Officer |
• – – |
2018-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,043 |
36,119 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
